Sulesomab is a radiopharmaceutical agent primarily used in medical imaging, particularly for the detection of infections and inflammatory conditions. It is a monoclonal antibody fragment that is labeled with a radioactive isotope, allowing for visualization through imaging techniques such as single-photon emission computed tomography (SPECT). The substance specifically targets the human granulocyte antigen, which is present on neutrophils, enabling it to localize in areas of infection or inflammation. Sulesomab is characterized by its high specificity and affinity for its target, which enhances the accuracy of diagnostic imaging. Its pharmacokinetics involve rapid distribution in the bloodstream, followed by accumulation in sites of infection, making it a valuable tool in clinical settings. Safety profiles indicate that it is generally well-tolerated, although, like all radiopharmaceuticals, it requires careful handling and administration due to the radioactive component. Overall, Sulesomab serves as an important diagnostic aid in the assessment of various inflammatory diseases.

Sulesomab

167747-19-5: Sulesomab is a radiopharmaceutical agent primarily used in medical imaging, particularly for the detection of infections and inflammatory conditions. It is a monoclonal antibody fragment that is labeled with a radioactive isotope, allowing for visualization through imaging techniques such as single-photon emission computed tomography (SPECT). The substance specifically targets the human granulocyte antigen, which is present on neutrophils, enabling it to localize in areas of infection or inflammation. Sulesomab is characterized by its high specificity and affinity for its target, which enhances the accuracy of diagnostic imaging. Its pharmacokinetics involve rapid distribution in the bloodstream, followed by accumulation in sites of infection, making it a valuable tool in clinical settings. Safety profiles indicate that it is generally well-tolerated, although, like all radiopharmaceuticals, it requires careful handling and administration due to the radioactive component. Overall, Sulesomab serves as an important diagnostic aid in the assessment of various inflammatory diseases.

<p>Sulesomab (IMMU-MN3), an IgG1 class murine monoclonal antibody fragment, targets the Normal Cross-Reactive Antigen-90 found on leukocytes.</p>

<p>Human mouse monoclonal antibody targeting NCA-90 (granulocyte cell antigen), imaging of infections and inflammation in osteomyelitis</p>

CAS 167747-19-5

Sulesomab

Sulesomab

Ref: TM-T81070

Sulesomab

Ref: 3D-CLA1113